Logo image of CBON

VANECK CHINA BOND ETF (CBON) Stock Price, Quote, News and Overview

NYSEARCA:CBON - NYSE Arca - US92189F3799 - ETF - Currency: USD

22.125  -0.04 (-0.16%)

Fundamental Rating

6

Taking everything into account, CBON scores 6 out of 10 in our fundamental rating. CBON was compared to 83 industry peers in the Automobile Components industry. CBON has an excellent profitability rating, but there are some minor concerns on its financial health. CBON has a bad growth rate and is valued cheaply. Finally CBON also has an excellent dividend rating. These ratings could make CBON a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

CBON had positive earnings in the past year.
CBON had a positive operating cash flow in the past year.
CBON had positive earnings in each of the past 5 years.
In the past 5 years CBON always reported a positive cash flow from operatings.
CBON Yearly Net Income VS EBIT VS OCF VS FCFCBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.28%, CBON is in the better half of the industry, outperforming 75.90% of the companies in the same industry.
CBON's Return On Equity of 10.77% is fine compared to the rest of the industry. CBON outperforms 74.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.29%, CBON is in the better half of the industry, outperforming 74.70% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBON is in line with the industry average of 9.58%.
The 3 year average ROIC (9.16%) for CBON is below the current ROIC(9.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROIC 9.29%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
CBON Yearly ROA, ROE, ROICCBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

CBON has a better Profit Margin (6.93%) than 79.52% of its industry peers.
CBON's Profit Margin has declined in the last couple of years.
CBON has a Operating Margin of 12.44%. This is amongst the best in the industry. CBON outperforms 81.93% of its industry peers.
CBON's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 29.25%, CBON is doing good in the industry, outperforming 73.49% of the companies in the same industry.
CBON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
CBON Yearly Profit, Operating, Gross MarginsCBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CBON is creating some value.
The number of shares outstanding for CBON remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CBON has less shares outstanding
CBON has a better debt/assets ratio than last year.
CBON Yearly Shares OutstandingCBON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
CBON Yearly Total Debt VS Total AssetsCBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.39 indicates that CBON is not a great score, but indicates only limited risk for bankruptcy at the moment.
CBON has a Altman-Z score (2.39) which is comparable to the rest of the industry.
The Debt to FCF ratio of CBON is 2.88, which is a good value as it means it would take CBON, 2.88 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.88, CBON is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
CBON has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
CBON's Debt to Equity ratio of 0.40 is fine compared to the rest of the industry. CBON outperforms 66.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Altman-Z 2.39
ROIC/WACC1.42
WACC6.55%
CBON Yearly LT Debt VS Equity VS FCFCBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.82 indicates that CBON should not have too much problems paying its short term obligations.
The Current ratio of CBON (1.82) is comparable to the rest of the industry.
CBON has a Quick Ratio of 1.11. This is a normal value and indicates that CBON is financially healthy and should not expect problems in meeting its short term obligations.
CBON has a Quick ratio of 1.11. This is comparable to the rest of the industry: CBON outperforms 56.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.11
CBON Yearly Current Assets VS Current LiabilitesCBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

CBON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.52%.
The Earnings Per Share has been growing slightly by 3.63% on average over the past years.
The Revenue has decreased by -5.57% in the past year.
Measured over the past years, CBON shows a small growth in Revenue. The Revenue has been growing by 5.17% on average per year.
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%

3.2 Future

The Earnings Per Share is expected to grow by 11.57% on average over the next years. This is quite good.
Based on estimates for the next years, CBON will show a small growth in Revenue. The Revenue will grow by 2.41% on average per year.
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBON Yearly Revenue VS EstimatesCBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CBON Yearly EPS VS EstimatesCBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

9

4. Valuation

4.1 Price/Earnings Ratio

CBON is valuated cheaply with a Price/Earnings ratio of 7.90.
CBON's Price/Earnings ratio is rather cheap when compared to the industry. CBON is cheaper than 80.72% of the companies in the same industry.
CBON's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
A Price/Forward Earnings ratio of 5.98 indicates a rather cheap valuation of CBON.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBON indicates a rather cheap valuation: CBON is cheaper than 86.75% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, CBON is valued rather cheaply.
Industry RankSector Rank
PE 7.9
Fwd PE 5.98
CBON Price Earnings VS Forward Price EarningsCBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

83.13% of the companies in the same industry are more expensive than CBON, based on the Enterprise Value to EBITDA ratio.
CBON's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CBON is cheaper than 83.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.12
EV/EBITDA 3.45
CBON Per share dataCBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBON may justify a higher PE ratio.
A more expensive valuation may be justified as CBON's earnings are expected to grow with 12.80% in the coming years.
PEG (NY)0.44
PEG (5Y)2.18
EPS Next 2Y13.1%
EPS Next 3Y12.8%

More info and screens

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.04%, CBON is a good candidate for dividend investing.
CBON's Dividend Yield is rather good when compared to the industry average which is at 4.03. CBON pays more dividend than 85.54% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, CBON pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.04%

5.2 History

The dividend of CBON is nicely growing with an annual growth rate of 7.12%!
CBON has been paying a dividend for at least 10 years, so it has a reliable track record.
CBON has decreased its dividend recently.
Dividend Growth(5Y)7.12%
Div Incr Years1
Div Non Decr Years1
CBON Yearly Dividends per shareCBON Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CBON pays out 50.00% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CBON is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
CBON Yearly Income VS Free CF VS DividendCBON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
CBON Dividend Payout.CBON Dividend Payout, showing the Payout Ratio.CBON Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK CHINA BOND ETF

NYSEARCA:CBON (2/21/2025, 8:05:40 PM)

22.125

-0.04 (-0.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-24 2025-04-24
Inst Owners39.74%
Inst Owner Change9.13%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.61B
Analysts75.71
Price Target24.86 (12.36%)
Short Float %0%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Yearly Dividend1.25
Dividend Growth(5Y)7.12%
DP50%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.62%
PT rev (3m)-2.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 7.9
Fwd PE 5.98
P/S 0.54
P/FCF 5.12
P/OCF 2.88
P/B 0.84
P/tB 1.15
EV/EBITDA 3.45
EPS(TTM)2.8
EY12.66%
EPS(NY)3.7
Fwd EY16.72%
FCF(TTM)4.32
FCFY19.54%
OCF(TTM)7.68
OCFY34.72%
SpS41.05
BVpS26.41
TBVpS19.32
PEG (NY)0.44
PEG (5Y)2.18
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROCE 12.25%
ROIC 9.29%
ROICexc 10.6%
ROICexgc 13.08%
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
FCFM 10.53%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ROICexc(3y)10.41%
ROICexc(5y)9.64%
ROICexgc(3y)12.74%
ROICexgc(5y)11.9%
ROCE(3y)12.06%
ROCE(5y)11.19%
ROICexcg growth 3Y13.26%
ROICexcg growth 5Y0.75%
ROICexc growth 3Y14.02%
ROICexc growth 5Y1.17%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Debt/EBITDA 1.31
Cap/Depr 116.24%
Cap/Sales 8.18%
Interest Coverage 10.15
Cash Conversion 96.06%
Profit Quality 152.03%
Current Ratio 1.82
Quick Ratio 1.11
Altman-Z 2.39
F-Score6
WACC6.55%
ROIC/WACC1.42
Cap/Depr(3y)109.9%
Cap/Depr(5y)100.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%
EBIT growth 1Y2.68%
EBIT growth 3Y23.2%
EBIT growth 5Y4.75%
EBIT Next Year61.62%
EBIT Next 3Y21.75%
EBIT Next 5Y16.53%
FCF growth 1Y7589.47%
FCF growth 3Y12.46%
FCF growth 5Y21.28%
OCF growth 1Y171.92%
OCF growth 3Y16.24%
OCF growth 5Y13.31%